ROR1 is a novel putative druggable target for diffuse glioma

التفاصيل البيبلوغرافية
العنوان: ROR1 is a novel putative druggable target for diffuse glioma
المؤلفون: Miya John, Padmashree Rao, Humaira Noor, Caroline Ford
بيانات النشر: Cold Spring Harbor Laboratory, 2021.
سنة النشر: 2021
الوصف: The cell surface receptor ROR1 is a therapeutic target of growing interest in oncology; however, its role in glioma has not been established thus far. This study analyzed associations between ROR1 mRNA expression and clinical outcomes, and histological and molecular subtypes in four independent glioma (grades II-IV) transcriptomic datasets (The Cancer Genome Atlas-GBMLGG, Chinese Glioma Genome Atlas, Repository for Molecular Brain Neoplasia, and GSE16011), encompassing a total of 2,388 cases. The data strongly suggests that ROR1 may be associated with poorer outcomes and more aggressive disease. Taken together, ROR1 should be further examined as a novel putative druggable target for glioma, a cancer that currently has very limited therapeutic options.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e0d5ea278b7274878d4d7e7c97892ba4
https://doi.org/10.1101/2021.12.03.21267166
حقوق: OPEN
رقم الأكسشن: edsair.doi...........e0d5ea278b7274878d4d7e7c97892ba4
قاعدة البيانات: OpenAIRE